BJDX Bluejay Diagnostics, Inc.

Overview and Growth

In fiscal 2025, Bluejay Diagnostics, Inc. reported net loss of $6.85M. Diluted earnings per share were -$15.25, translating the period’s attributable earnings into the amount reported for each diluted share. Diluted shares averaged 449.04K; this is the reported share base over which the company’s diluted per-share earnings were spread. Compared with 45.85K diluted shares in fiscal 2024, the current 449.04K base was 879.4% higher. Total assets stood at $7.12M, showing the scale of resources supporting revenue, earnings, liquidity, and financing.

Profitability

The company recorded an operating loss of $6.95M after the reported operating expense base. After all below-operating-line items, the company recorded a net loss of $6.85M for the fiscal year. EBITDA was negative $6.88M, showing a deficit before interest, taxes, depreciation, and amortization. Relative to period-end equity, the net loss represented 114.6%. The loss-to-assets relationship was 96.2%, placing the bottom-line deficit against the company’s resource base. The net loss narrowed to $6.85M from $7.72M in fiscal 2024.

Liquidity and Capital Structure

Total assets were $7.12M, supported by $1.14M of liabilities and $5.98M of shareholder equity. The near-term balance sheet paired $5.46M of current assets with $1.12M of current liabilities at the reporting date. At 4.88x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. The company held $5.16M in cash and equivalents, a narrower liquidity measure than total current assets. The cash balance equaled 461.5% of current liabilities, showing how much near-term coverage came from cash alone. Equity equaled 83.9% of assets, showing the shareholder-capital layer within the company’s balance sheet. Liabilities represented 16.1% of total assets, quantifying the liability-funded share of the company’s resource base. The cash-to-assets relationship was 72.5%, comparing reported cash and equivalents with the full positive asset balance. Total assets were 6.9% higher than fiscal 2024 assets of $6.66M, measuring the company’s own balance-sheet change. Reported equity changed 4.3% from $5.73M in fiscal 2024, placing the current capital base higher year over year. The reported cash balance changed 20.1% from $4.30M in fiscal 2024, ending higher year over year.

Cash Flow and Earnings Quality

Operating activities used $6.05M of cash, resulting in an operating cash outflow for the year. The company spent $173.74K on capital expenditures while operations also absorbed cash, so both ongoing activity and investment drew on liquidity during the period. Negative free cash flow was $6.23M, leaving a cash deficit after capital spending and reducing financial flexibility. The free-cash-flow deficit equaled 87.5% of total assets, placing the cash shortfall against the company’s resource base. Compared with a $7.82M operating cash outflow in fiscal 2024, the current outflow improved to $6.05M.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Sep 24, 2026.